BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6336656)

  • 21. Development of high sensitive umu test system: rapid detection of genotoxicity of promutagenic aromatic amines by Salmonella typhimurium strain NM2009 possessing high O-acetyltransferase activity.
    Oda Y; Yamazaki H; Watanabe M; Nohmi T; Shimada T
    Mutat Res; 1995 Apr; 334(2):145-56. PubMed ID: 7885366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine bladder and liver cell and homogenate-mediated mutagenesis of Salmonella typhimurium with aromatic amines.
    Hix C; Oglesby L; MacNair P; Sieg M; Langenbach R
    Carcinogenesis; 1983 Nov; 4(11):1401-7. PubMed ID: 6357520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a newly developed tester strain Salmonella typhimurium NM2009 for the study of metabolic activation of carcinogenic aromatic amines by rat liver microsomal cytochrome P-450 enzymes.
    Yamazaki H; Oda Y; Shimada T
    Mutat Res; 1992 Oct; 272(2):183-92. PubMed ID: 1383750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purified prostaglandin synthase activates aromatic amines to derivatives that are mutagenic to Salmonella typhimurium.
    Sarkar FH; Radcliff G; Callewaert DM
    Mutat Res; 1992 Aug; 282(4):273-81. PubMed ID: 1379690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The oxidation of 2-aminofluorene by prostaglandin endoperoxide synthetase. Comparison with other peroxidases.
    Boyd JA; Harvan DJ; Eling TE
    J Biol Chem; 1983 Jul; 258(13):8246-54. PubMed ID: 6408086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic differences in metabolism of polycyclic aromatic carcinogens and aromatic amines by mouse liver microsomes. Detection by DNA binding of metabolites and by mutagenicity in histidine-dependent Salmonella typhimurium in vitro.
    Levitt RC; Pelkonen O; Okey AB; Nebert DW
    J Natl Cancer Inst; 1979 Apr; 62(4):947-55. PubMed ID: 372661
    [No Abstract]   [Full Text] [Related]  

  • 27. Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis.
    Sivarajah K; Lasker JM; Eling TE; Abou-Donia MB
    Mol Pharmacol; 1982 Jan; 21(1):133-41. PubMed ID: 6813675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenic synergy between paraoxon and mammalian or plant-activated aromatic amines.
    Wagner ED; Repetny K; Tan JS; Gichner T; Plewa MJ
    Environ Mol Mutagen; 1997; 30(3):312-20. PubMed ID: 9366910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenicity of amine drugs and their products of nitrosation.
    Andrews AW; Lijinsky W; Snyder SW
    Mutat Res; 1984 Feb; 135(2):105-8. PubMed ID: 6363913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenicity of aromatic amines and amides with chemical models for cytochrome P450 in Ames assay.
    Inami K; Okazawa M; Mochizuki M
    Toxicol In Vitro; 2009 Sep; 23(6):986-91. PubMed ID: 19563884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apparent activation of 2-acetylaminofluorene and some aromatic amines by cytosolic preparations.
    Forster R; Green MH; Priestley A; Gorrod JW
    Mutat Res; 1981 Aug; 85(4):187-94. PubMed ID: 7022188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin H synthase-dependent genotoxicity of 2,4-diaminotoluene.
    Pan YH; Reddy GR; Reed GA
    Environ Mol Mutagen; 1992; 19(3):201-8. PubMed ID: 1572343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver, kidney and small-intestine microsomal-mediated mutagenicity of carcinogenic aromatic amines.
    Fouarge M; Mercier M; Poncelet F
    Mutat Res; 1984 Jan; 125(1):23-31. PubMed ID: 6361544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene.
    Robertson IG
    Mutat Res; 1986 Nov; 175(3):153-7. PubMed ID: 3534560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagenicity of aminocarbazoles and nitrocarbazoles.
    LaVoie EJ; Govil A; Briggs G; Hoffmann D
    Mutat Res; 1981 Dec; 90(4):337-44. PubMed ID: 7038457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin synthetase dependent activation of 7,8-dihydro-7,8-dihydroxy-geno (a) pyrene to mutagenic derivativies.
    Marnett LJ; Reed GA; Dennison DJ
    Biochem Biophys Res Commun; 1978 May; 82(1):210-6. PubMed ID: 96834
    [No Abstract]   [Full Text] [Related]  

  • 37. Activation of some aromatic amines to mutagenic products by human red blood cell cytosol.
    Duverger-van Bogaert M; Crutzen-Fayt MC; Stecca C
    Mutat Res; 1991 Aug; 263(4):249-55. PubMed ID: 1861690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin H synthase-dependent mutagenic activation of heterocyclic aromatic amines of the IQ-type.
    Wild D; Degen GH
    Carcinogenesis; 1987 Apr; 8(4):541-5. PubMed ID: 3103946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DIfferential ability of Ambystoma tigrinum hepatic microsomes to produce mutagenic metabolites from polycyclic aromatic hydrocarbons and aromatic amines.
    Anderson RS; Döös EJ; Rose FL
    Cancer Lett; 1982; 16(1):33-41. PubMed ID: 6288233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin-H synthase mediated metabolism and mutagenic activation of 2-amino-3-methylimidazo [4,5-f] quinoline (IQ).
    Wolz E; Wild D; Degen GH
    Arch Toxicol; 1995; 69(3):171-9. PubMed ID: 7717873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.